ROCHE HOLDING LTD's Net Worth
-$3.13 Billion
Who is ROCHE HOLDING LTD?
ROCHE HOLDING LTD does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Senseonics Holdings, Inc., Allakos Inc., Entrada Therapeutics, Inc., Foundation Medicine, Inc., Jasper Therapeutics, Inc., Pandion Therapeutics, Inc., AILERON THERAPEUTICS INC, Spark Therapeutics, Inc., Aligos Therapeutics, Inc., and BIOVERIS CORP.
SEC CIK
ROCHE HOLDING LTD's CIK is 0000889131
Past Insider Trading and Trends
2018 was ROCHE HOLDING LTD's most active year for acquiring shares with 3 total transactions. ROCHE HOLDING LTD's most active month to acquire stocks was the month of June. 2017 was ROCHE HOLDING LTD's most active year for disposing of shares, totalling 4 transactions. ROCHE HOLDING LTD's most active month to dispose stocks was the month of June. 2018 saw ROCHE HOLDING LTD paying a total of $2,222,280,699.00 for 20,831,750 shares, this is the most they've acquired in one year. In 2023 ROCHE HOLDING LTD cashed out on 75,000 shares for a total of $141,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Senseonics Holdings, Inc. (SENS) Snapshot price: $0.5302
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allakos Inc. (ALLK) Snapshot price: $1.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.61M |
—
|
—
| 4.61M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.81M |
—
|
—
| 2.81M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foundation Medicine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +78.73% | 16.22M |
$137.00 | $2,222,280,699.00 | 36.83M |
Jul 31
| |||
Form 4
|
∞
| 20.6M |
$50.00 | $1,030,214,400.00 | 20.6M |
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $17.665
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.62% | -75.00K |
$1.89 | -$141,750.00 | 4.55M |
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||